Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 1
2016 2
2017 3
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.
Derigs P, Radujkovic A, Schubert ML, Schnitzler P, Schöning T, Müller-Tidow C, Hegenbart U, Schönland SO, Luft T, Dreger P, Schmitt M. Derigs P, et al. Among authors: schoning t. Ann Hematol. 2021 Aug;100(8):2087-2093. doi: 10.1007/s00277-020-04362-2. Epub 2020 Dec 3. Ann Hematol. 2021. PMID: 33270162 Free PMC article.
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A, Markert A, Askoxylakis V, Schöning T, Jesenofsky R, Eisenhut M, Haberkorn U. Altmann A, et al. Among authors: schoning t. J Nucl Med. 2012 Nov;53(11):1764-71. doi: 10.2967/jnumed.111.101295. Epub 2012 Oct 10. J Nucl Med. 2012. PMID: 23055533 Free article.
In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study.
Cremer M, Schwarzbich MA, Schöning T, Lisenko K, Ho AD, Witzens-Harig M. Cremer M, et al. Among authors: schoning t. Ann Hematol. 2017 Sep;96(9):1573-1575. doi: 10.1007/s00277-017-3044-4. Epub 2017 Jun 16. Ann Hematol. 2017. PMID: 28623395 No abstract available.
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.
Schwarzbich MA, Schöning T, Cremer M, Lisenko K, Ho AD, Witzens-Harig M. Schwarzbich MA, et al. Among authors: schoning t. Leuk Lymphoma. 2016 Jul;57(7):1723-6. doi: 10.3109/10428194.2015.1113274. Epub 2016 Mar 16. Leuk Lymphoma. 2016. PMID: 26980422 No abstract available.
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.
Geletneky K, Hajda J, Angelova AL, Leuchs B, Capper D, Bartsch AJ, Neumann JO, Schöning T, Hüsing J, Beelte B, Kiprianova I, Roscher M, Bhat R, von Deimling A, Brück W, Just A, Frehtman V, Löbhard S, Terletskaia-Ladwig E, Fry J, Jochims K, Daniel V, Krebs O, Dahm M, Huber B, Unterberg A, Rommelaere J. Geletneky K, et al. Among authors: schoning t. Mol Ther. 2017 Dec 6;25(12):2620-2634. doi: 10.1016/j.ymthe.2017.08.016. Epub 2017 Aug 24. Mol Ther. 2017. PMID: 28967558 Free PMC article. Clinical Trial.
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.
Hajda J, Lehmann M, Krebs O, Kieser M, Geletneky K, Jäger D, Dahm M, Huber B, Schöning T, Sedlaczek O, Stenzinger A, Halama N, Daniel V, Leuchs B, Angelova A, Rommelaere J, Engeland CE, Springfeld C, Ungerechts G. Hajda J, et al. Among authors: schoning t. BMC Cancer. 2017 Aug 29;17(1):576. doi: 10.1186/s12885-017-3604-y. BMC Cancer. 2017. PMID: 28851316 Free PMC article. Clinical Trial.
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases.
Rohlfing S, Aurich M, Schöning T, Ho AD, Witzens-Harig M. Rohlfing S, et al. Among authors: schoning t. Clin Lymphoma Myeloma Leuk. 2015 Aug;15(8):458-63. doi: 10.1016/j.clml.2015.03.008. Epub 2015 Mar 24. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25899891
11 results